eMedicine Specialties > Ophthalmology > Intraocular Pressure
Glaucoma, Neovascular: Follow-up
Updated: Jun 26, 2006
Follow-up
Further Outpatient Care
- Ophthalmologists should provide long-term follow-up care for patients with NVG, closely monitoring for any worsening in the patient's condition.
- Intensity of follow-up care is related to the conditions predisposing the patient to the development of NVG (ie, CRVO, diabetic retinopathy).
Complications
- Complications include uncontrolled glaucoma, hyphema, and loss of vision.
Prognosis
- Generally, NVG carries a very guarded prognosis. Prognosis is highly dependent on the following 2 factors: prevention and treatment of NVG early in its course and the underlying disease process.
Patient Education
- Patients with NVG must be educated about the disease process and its poor prognosis.
- For excellent patient education resources visit eMedicine's Glaucoma Center and Diabetes Center. Also, see eMedicine's patient education articles Glaucoma Overview, Glaucoma FAQs, Understanding Glaucoma Medications, and Diabetic Eye Disease.
Miscellaneous
Medicolegal Pitfalls
- Early detection of NVG and patient education about its poor prognosis are essential.
More on Glaucoma, Neovascular |
| Overview: Glaucoma, Neovascular |
| Differential Diagnoses & Workup: Glaucoma, Neovascular |
| Treatment & Medication: Glaucoma, Neovascular |
Follow-up: Glaucoma, Neovascular |
| References |
| « Previous Page |
References
Albert DM, Jakobiec FA. Neovascular glaucoma. Principles and Practice of Ophthalmology, Clinical Ophthalmology [book on CD-ROM]. Chapter 215.
Browning DJ, Scott AQ, Peterson CB. The risk of missing angle neovascularization by omitting screening gonioscopy in acute central retinal vein occlusion. Ophthalmology. May 1998;105(5):776-84. [Medline].
Epstein DL, Allingham RR, Schuman JS. Chandler and Grant's Glaucoma. 4th ed. 1997;309-18.
Gupta V, Agarwal HC. Contact trans-scleral diode laser cyclophotocoagulation treatment for refractory glaucomas in the Indian population. Indian J Ophthalmol. Dec 2000;48(4):295-300. [Medline].
Lieberman MF, Ewing RH. Drainage implant surgery for refractory glaucoma. Int Ophthalmol Clin. Summer 1990;30(3):198-208. [Medline].
Muller VA, Ruokonen P, Schellenbeck M, et al. Treatment of rubeosis iridis with photodynamic therapy with verteporfin--A new therapeutic and prophylactic option for patients with the risk of neovascular glaucoma?. Ophthalmic Res. Jan-Feb 2003;35(1):60-4. [Medline].
Parodi MB, Iacono P. Photodynamic therapy with verteporfin for anterior segment neovascularizations in neovascular glaucoma. Am J Ophthalmol. Jul 2004;138(1):157-8. [Medline].
Schlote T, Derse M, Rassmann K. Efficacy and safety of contact transscleral diode laser cyclophotocoagulation for advanced glaucoma. J Glaucoma. Aug 2001;10(4):294-301. [Medline].
Shields MB. Textbook of Glaucoma. 4th ed. 1998;269-86.
Sivak-Callcott JA, O''Day DM, Gass JD. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology. Oct 2001;108(10):1767-76; quiz 1777, 1800. [Medline].
The Central Vein Occlusion Study Group. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report. Ophthalmology. Oct 1995;102(10):1434-44. [Medline].
Tripathi RC, Li J, Tripathi BJ. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology. Feb 1998;105(2):232-7. [Medline].
Further Reading
Keywords
NVG, open angle, closed angle, vision loss, visual deficit, secondary glaucoma, hemorrhagic glaucoma, thrombotic glaucoma, congestive glaucoma, rubeotic glaucoma, diabetic hemorrhagic glaucoma
Follow-up: Glaucoma, Neovascular